Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T09:38:24.271Z Has data issue: false hasContentIssue false

Paediatric giant cell myocarditis: a case report

Published online by Cambridge University Press:  06 December 2021

Guilherme Lourenço*
Affiliation:
Paediatric Cardiology Department, Congenital Heart Disease Reference Centre, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
João Pimentel
Affiliation:
Anatomic Pathology Department, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
Conceição Trigo
Affiliation:
Paediatric Cardiology Department, Congenital Heart Disease Reference Centre, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
Fátima F. Pinto
Affiliation:
Paediatric Cardiology Department, Congenital Heart Disease Reference Centre, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
*
Author for correspondence: G. Lourenço, MD, Paediatric Cardiology Department, Congenital Heart Disease Reference Centre, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Rua de Santa Marta 50, 1169-024Lisbon, Portugal. Tel: +351 21 359 43 32. E-mail: guilhermepcl@gmail.com

Abstract

A previously healthy 15-year-old teenage boy was admitted for fever and heart failure. Myocarditis was suspected, and endomyocardial biopsy revealed giant cell myocarditis. Immunosuppressive treatment was initiated, with excellent response. A plausible link to previous leptospirosis was identified. At 18-month follow-up, left ventricular function is normal. Only one other reported case of paediatric giant cell myocarditis had such a favourable outcome.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cooper, LT, Berry, GJ, Shabetai, R. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 18601866.10.1056/NEJM199706263362603CrossRefGoogle ScholarPubMed
Kandolin, R, Lehtonen, J, Salmenkivi, K, Räisänen-Sokolowski, A, Lommi, J, Kupari, M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail 2013; 6: 1522.CrossRefGoogle ScholarPubMed
Cooper, LT. Giant cell myocarditis in children. Prog Pediatr Cardiol 2007; 24: 4749.CrossRefGoogle ScholarPubMed
Das, BB, Recto, M, Johnsrude, C, et al. Cardiac transplantation for pediatric giant cell myocarditis. J Heart Lung Transplant 2006; 25: 474478.CrossRefGoogle ScholarPubMed
Lind-Ayres, MR, Abramowsky, C, Mahle, WT. Pediatric giant cell myocarditis and orbital myositis. Pediatr Cardiol 2009; 30: 510512.CrossRefGoogle ScholarPubMed
Blauwet, LA, Cooper, LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev 2013; 18: 733746.CrossRefGoogle ScholarPubMed
Vaideeswar, P, Cooper, LT. Giant cell myocarditis: clinical and pathological features in an Indian population. Cardiovasc Pathol 2013; 22: 7074.CrossRefGoogle Scholar
Levett, PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 296326.10.1128/CMR.14.2.296-326.2001CrossRefGoogle ScholarPubMed
Kalra, A, Kneeland, R, Samara, MA, Cooper, LT. The changing role for endomyocardial biopsy in the diagnosis of giant-cell myocarditis. Cardiol Ther 2014; 3: 5359.CrossRefGoogle Scholar
Maleszewski, JJ, Orellana, VM, Hodge, DO, Kuhl, U, Schultheiss, HP, Cooper, LT. Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. Am J Cardiol 2015; 115: 17331738.CrossRefGoogle ScholarPubMed
Supplementary material: File

Lourenço et al. supplementary material

Lourenço et al. supplementary material

Download Lourenço et al. supplementary material(File)
File 24.6 KB